Page last updated: 2024-10-31

metyrapone and Thalassemias

metyrapone has been researched along with Thalassemias in 3 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rosenbloom, BE1
Odell, WD1
Tanaka, KR1
Kuo, B2
Zaino, E1
Roginsky, MS2
Zaino, EC1

Other Studies

3 other studies available for metyrapone and Thalassemias

ArticleYear
Pituitary-adrenal axis function in sickle cell anemia and its relationship to leukocyte alkaline phosphatase.
    American journal of hematology, 1980, Volume: 9, Issue:4

    Topics: Adult; Alkaline Phosphatase; Anemia, Sickle Cell; Blood Glucose; Cortodoxone; Female; Growth Hormone

1980
Endocrine function in thalassemia major.
    The Journal of clinical endocrinology and metabolism, 1968, Volume: 28, Issue:6

    Topics: 17-Ketosteroids; Adolescent; Adrenal Glands; Adult; Age Determination by Skeleton; Body Height; Body

1968
Growth retardation in thalassemia major.
    Annals of the New York Academy of Sciences, 1969, Nov-20, Volume: 165, Issue:1

    Topics: 17-Ketosteroids; Adolescent; Adrenal Glands; Adult; Blood Transfusion; Child; Female; Gonadotropins,

1969